We analyzed MMP expression to assess the anti-osteoarthritis effects of LI73014F2 and showed that a 50 mg/kg dose of the compound significantly reduced MMP-2, MMP-3, and MMP-13 levels. Here, MMP13 is linked to osteoarthritis.